Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Only secondary literature. Original report not available.

Data source

Referenceopen allclose all

Reference Type:
secondary source
Title:
Diesters Category of the Aliphatic Esters Chemicals (Test Plan and Robust Summaries for Substances in the HPV Test Plan)
Author:
US-EPA (American Chemistry Council's Aliphatic Esters Panel)
Year:
2010
Bibliographic source:
High Production Volume (HPV) Chemical Challenge Program (201-16837A and 201-16837B)
Reference Type:
secondary source
Title:
Toxicity Profile for Di(2-ethylhexyl) Sebacate
Author:
British Industrial Biological Research Association (BIBRA)
Year:
1996
Bibliographic source:
as cited in US-EPA (2010) Diesters Category of the Aliphatic Esters Chemicals

Materials and methods

Principles of method if other than guideline:
1, 7, or 13-week inhalation study, no further details given.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Bis(2-ethylhexyl) sebacate
EC Number:
204-558-8
EC Name:
Bis(2-ethylhexyl) sebacate
Cas Number:
122-62-3
Molecular formula:
C26H50O4
IUPAC Name:
bis(2-ethylhexyl) sebacate
Details on test material:
- Analytical purity: no data

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
not specified

Administration / exposure

Route of administration:
inhalation
Type of inhalation exposure:
not specified
Vehicle:
not specified
Remarks on MMAD:
MMAD / GSD: no data
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
1, 7, or 13 weeks
Frequency of treatment:
5 days/week; 4 h/day
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
25 and 250 mg/m³
Basis:
nominal conc.
Remarks:
Doses / Concentrations:
0.025 and 0.25 mg/L
Basis:
nominal conc.
No. of animals per sex per dose:
12 rats/dose
Control animals:
yes

Results and discussion

Effect levels

Dose descriptor:
NOAEC
Effect level:
250 mg/m³ air (nominal)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: no adverse systemic or lung effects at the highest concentration

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

There were no adverse systemic or lung effects seen in groups of 12 rats exposed to up to 250 mg/m³ for 4 h/day, 5 days/week for 13 weeks.

Applicant's summary and conclusion